229 filings
8-K
MSLPQ
MusclePharm Corp
31 Aug 23
Departure of Directors or Certain Officers
5:23pm
8-K
MSLPQ
MusclePharm Corp
19 Jul 23
Departure of Directors or Certain Officers
3:06pm
8-K
MSLPQ
MusclePharm Corp
10 Mar 23
Departure of Directors or Certain Officers
4:16pm
8-K
MSLPQ
MusclePharm Corp
11 Jan 23
Bankruptcy or Receivership
5:02pm
8-K
MSLPQ
MusclePharm Corp
10 Jan 23
Changes in Registrant's Certifying Accountant
7:37pm
8-K
dx2e4m 0o
9 Jan 23
Bankruptcy or Receivership
2:41pm
8-K
r2hvwmqte
29 Sep 22
Departure of Directors or Certain Officers
4:33pm
8-K
gwde2rf6
16 Sep 22
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:43pm
8-K
eenlcwphnt9uxlvn
23 Aug 22
Departure of Directors or Certain Officers
4:53pm
8-K
syu5j4
22 Aug 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:09pm
8-K
46fuw7e
28 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
9p36hk jrzo
12 Jul 22
Departure of Directors or Certain Officers
5:00pm
8-K
6obiuoxd3
22 Jun 22
Departure of Directors or Certain Officers
4:05pm
8-K
0g14o7483 tc
14 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
ihqz6q10d39 du6cb
9 Jun 22
Entry into a Material Definitive Agreement
4:27pm
8-K
ls6j yrsf17126
17 May 22
MusclePharm Announces First Quarter 2022 Financial Results
4:15pm
8-K
ug4n8
5 May 22
Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021
4:55pm
8-K
lem0kt22
28 Apr 22
MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results
8:15am
8-K
abs41i60gnxxzmqomvhd
11 Mar 22
Entry into a Material Definitive Agreement
4:55pm
8-K
ivrtj
29 Dec 21
Departure of Directors or Certain Officers
4:04pm